294 related articles for article (PubMed ID: 16036766)
1. Weak inhibitors protect cholinesterases from stronger inhibitors (dichlorvos): in vitro effect of tiapride.
Petroianu GA; Schmitt A; Arafat K; Hasan MY
Int J Toxicol; 2005; 24(2):79-86. PubMed ID: 16036766
[TBL] [Abstract][Full Text] [Related]
2. Weak inhibitors protect cholinesterases from strong inhibitors (paraoxon): in vitro effect of tiapride.
Petroianu GA; Hasan MY; Arafat K; Nurulain SM; Schmitt A
J Appl Toxicol; 2005; 25(6):562-7. PubMed ID: 16193528
[TBL] [Abstract][Full Text] [Related]
3. Weak inhibitors protect cholinesterases from strong inhibitors (paraoxon): in vitro effect of ranitidine.
Petroianu GA; Arafat K; Schmitt A; Hasan MY
J Appl Toxicol; 2005; 25(1):60-7. PubMed ID: 15669026
[TBL] [Abstract][Full Text] [Related]
4. In vitro protection of red blood cell acetylcholinesterase by metoclopramide from inhibition by organophosphates (paraoxon and mipafox).
Petroianu G; Arafat K; Kosanovic M; Saleh A; Camasamudram V; Hasan MY
J Appl Toxicol; 2003; 23(6):447-51. PubMed ID: 14635269
[TBL] [Abstract][Full Text] [Related]
5. In vitro protection of plasma cholinesterases by metoclopramide from inhibition by paraoxon.
Petroianu G; Kühn F; Thyes C; Ewald V; Missler A
J Appl Toxicol; 2003; 23(1):75-9. PubMed ID: 12518340
[TBL] [Abstract][Full Text] [Related]
6. In vitro protection of plasma cholinesterases by metoclopramide from inhibition by mipafox.
Petroianu G; Kühn F; Arafat K; Zuleger K; Missler A
J Appl Toxicol; 2004; 24(2):143-6. PubMed ID: 15052610
[TBL] [Abstract][Full Text] [Related]
7. Five oximes (K-27, K-33, K-48, BI-6 and methoxime) in comparison with pralidoxime: in vitro reactivation of red blood cell acetylcholinesterase inhibited by paraoxon.
Petroianu GA; Arafat K; Kuca K; Kassa J
J Appl Toxicol; 2006; 26(1):64-71. PubMed ID: 16193529
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo effects of dichlorvos on blood cholinesterase activities of cattle.
Khan AA; Coppock RW; Schuler MM; Lillie LE
Am J Vet Res; 1988 Jul; 49(7):1184-7. PubMed ID: 3421541
[TBL] [Abstract][Full Text] [Related]
9. Effects of dichlorvos on blood cholinesterase activities of cattle.
Khan AA; Coppock RW; Schuler MM; Lillie LE
Am J Vet Res; 1990 Jan; 51(1):79-82. PubMed ID: 2301824
[TBL] [Abstract][Full Text] [Related]
10. In vitro oxime reactivation of red blood cell acetylcholinesterase inhibited by methyl-paraoxon.
Petroianu GA; Arafat K; Nurulain SM; Kuca K; Kassa J
J Appl Toxicol; 2007; 27(2):168-75. PubMed ID: 17265452
[TBL] [Abstract][Full Text] [Related]
11. Oral administration of pyridostigmine bromide and huperzine A protects human whole blood cholinesterases from ex vivo exposure to soman.
Gordon RK; Haigh JR; Garcia GE; Feaster SR; Riel MA; Lenz DE; Aisen PS; Doctor BP
Chem Biol Interact; 2005 Dec; 157-158():239-46. PubMed ID: 16256090
[TBL] [Abstract][Full Text] [Related]
12. In vitro oxime protection of human red blood cell acetylcholinesterase inhibited by diisopropyl-fluorophosphate.
Lorke DE; Hasan MY; Arafat K; Kuca K; Musilek K; Schmitt A; Petroianu GA
J Appl Toxicol; 2008 May; 28(4):422-9. PubMed ID: 18344198
[TBL] [Abstract][Full Text] [Related]
13. Protection of red blood cell acetylcholinesterase by oral huperzine A against ex vivo soman exposure: next generation prophylaxis and sequestering of acetylcholinesterase over butyrylcholinesterase.
Haigh JR; Johnston SR; Peppernay A; Mattern PJ; Garcia GE; Doctor BP; Gordon RK; Aisen PS
Chem Biol Interact; 2008 Sep; 175(1-3):380-6. PubMed ID: 18572153
[TBL] [Abstract][Full Text] [Related]
14. Metoclopramide protection of cholinesterase from paraoxon inhibition.
Petroianu GA; Hasan MY; Kosanovic M; Vijayasarathy C; Saleh AM
Vet Hum Toxicol; 2003 Oct; 45(5):251-3. PubMed ID: 14513894
[TBL] [Abstract][Full Text] [Related]
15. Differential cholinesterase inhibition in the rat brain regions by dichlorvos and protective effect of Decalepis hamiltonii roots.
Srivastava A; Shivanandappa T
Neurotoxicology; 2011 Dec; 32(6):931-4. PubMed ID: 21571001
[TBL] [Abstract][Full Text] [Related]
16. In vivo metoclopramide protection of cholinesterase from paraoxon inhibition: direct comparison with pralidoxime in subchronic low-dose exposure.
Hasan MY; Nurulain SM; Arafat K; Naseer OP; Petroianu GA
J Appl Toxicol; 2004; 24(4):257-60. PubMed ID: 15300712
[TBL] [Abstract][Full Text] [Related]
17. Protective drugs in acute large-dose exposure to organophosphates: a comparison of metoclopramide and tiapride with pralidoxime in rats.
Petroianu GA; Hasan MY; Nurulain SM; Arafat K; Sheen R; Saleh A; Schmitt A
Anesth Analg; 2005 Feb; 100(2):382-386. PubMed ID: 15673862
[TBL] [Abstract][Full Text] [Related]
18. Variable response of cholinesterase activities following human exposure to different types of organophosphates.
Moon J; Chun B; Lee S
Hum Exp Toxicol; 2015 Jul; 34(7):698-706. PubMed ID: 25712411
[TBL] [Abstract][Full Text] [Related]
19. Suitability of human butyrylcholinesterase as therapeutic marker and pseudo catalytic scavenger in organophosphate poisoning: a kinetic analysis.
Aurbek N; Thiermann H; Eyer F; Eyer P; Worek F
Toxicology; 2009 May; 259(3):133-9. PubMed ID: 19428953
[TBL] [Abstract][Full Text] [Related]
20. Testing of antidotes for organophosphorus compounds: experimental procedures and clinical reality.
Eyer P; Szinicz L; Thiermann H; Worek F; Zilker T
Toxicology; 2007 Apr; 233(1-3):108-19. PubMed ID: 17010492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
